Solid tumors
The appropriate pediatric blood-care service depends on the confirmed diagnosis, severity, patient factors and whether it will change treatment or function.
Related treatment guides: CAR-T Cell Therapy
Specialty and country guide
Pediatric hematology manages blood and marrow disorders in infants, children and adolescents using age- and weight-specific assessment. The pathway must account for diagnosis, growth, development, prior treatment, infection and transfusion history, donor options and long-term effects.
Specialty overview
Pediatric hematology manages blood and marrow disorders in infants, children and adolescents using age- and weight-specific assessment. The pathway must account for diagnosis, growth, development, prior treatment, infection and transfusion history, donor options and long-term effects.
A specialty label is not a treatment recommendation. Safe planning requires age-specific disease classification and dosing, growth, fertility and late-effect considerations, family support, donor assessment and pediatric intensive-care access. The named pediatric hematologist must review original records and explain alternatives, material risks, expected recovery and follow-up before travel or cost is finalized.
The directory below uses current catalog relationships for 10 pediatric blood-care services. It does not rank clinicians or guarantee that every service is available at every campus. GAF confirms the doctor, hospital, clinical scope and written estimate for an individual case.
Clinical scope
A specialty can have diagnostic, medical, procedural, supportive or palliative roles. A diagnosis alone does not establish that any listed pediatric blood-care service is appropriate.
The appropriate pediatric blood-care service depends on the confirmed diagnosis, severity, patient factors and whether it will change treatment or function.
Related treatment guides: CAR-T Cell Therapy
The appropriate pediatric blood-care service depends on the confirmed diagnosis, severity, patient factors and whether it will change treatment or function.
Related treatment guides: CAR-T Cell Therapy, Autologous Stem Cell Transplant, Allogeneic Stem Cell Transplant, Haploidentical Stem Cell Transplant
The appropriate pediatric blood-care service depends on the confirmed diagnosis, severity, patient factors and whether it will change treatment or function.
Related treatment guides: CAR-T Cell Therapy, Autologous Stem Cell Transplant, Allogeneic Stem Cell Transplant, Haploidentical Stem Cell Transplant
The appropriate pediatric blood-care service depends on the confirmed diagnosis, severity, patient factors and whether it will change treatment or function.
Related treatment guides: Autologous Stem Cell Transplant, Allogeneic Stem Cell Transplant, Haploidentical Stem Cell Transplant, Bone Marrow Biopsy
The appropriate pediatric blood-care service depends on the confirmed diagnosis, severity, patient factors and whether it will change treatment or function.
Related treatment guides: Pediatric Bone Marrow Transplantation, Matched Sibling Donor Transplant, Hematopoietic Stem Cell Transplantation
pediatric blood-care services
The 10 current pediatric blood-care service records in India are grouped by clinical approach. Every link opens a separate cost guide; a service or platform name is not a treatment recommendation.
These catalog services share a broad delivery setting, but each keeps its own indication, technique, risks, duration and written estimate.
CAR-T cell therapy collects a patient's T cells, genetically engineers them to recognise a cancer target, expands them, then returns them after lymphodepleting treatment.
An autologous stem cell transplant collects and cryopreserves the patient's own blood-forming stem cells, gives high-dose chemotherapy, then returns those cells to restore marrow production.
An allogeneic stem cell transplant replaces blood formation with stem cells from another person after conditioning and adds a donor immune effect against selected blood cancers or marrow disorders.
A haploidentical transplant is an allogeneic transplant from a related donor who shares one HLA haplotype, commonly a parent, child or partially matched sibling.
A matched unrelated donor transplant is an allogeneic stem cell transplant using a volunteer donor selected through a registry by high-resolution HLA matching and medical suitability.
Pediatric bone marrow transplantation is a children’s-unit haematopoietic transplant: weight-based conditioning, a named paediatric isolation floor and a parent who can stay through the infection window, rather than an adult transplant admission that happens to accept a child.
A matched sibling donor transplant is an allogeneic transplant in which a brother or sister is a fully HLA-matched donor after independent medical assessment, not simply because the children share a household.
Hematopoietic stem cell transplantation in this catalog is the paediatric graft-source programme: marrow, peripheral-blood stem cells or cord blood chosen and dosed for a child’s weight, delivered by a named paediatric transplant physician on a unit that already treats children.
These catalog services share a broad delivery setting, but each keeps its own indication, technique, risks, duration and written estimate.
A bone marrow biopsy removes a small core of marrow, usually from the posterior pelvic bone, so architecture, cellularity, fibrosis and infiltrating disease can be examined by haematopathology.
Bone marrow aspiration withdraws liquid marrow, usually from the posterior iliac crest, for cell morphology, flow cytometry, cytogenetics, molecular testing or microbiology.
Compare
These are current GAF catalog planning ranges, separated by compatible billing basis. A cycle, course, operation, test and treatment programme are not interchangeable units.
Per complete named programme
Compare only estimates that name the same clinical scope, technique, devices, admission, monitoring and exclusions.
Per diagnostic or assessment episode
Compare only estimates that name the same clinical scope, technique, devices, admission, monitoring and exclusions.
| pediatric blood-care service | What it is used for | Typical course or stay | Pricing basis | GAF India planning range | Details |
|---|---|---|---|---|---|
| CAR-T Cell Therapy | CAR-T cell therapy collects a patient's T cells, genetically engineers them to recognise a cancer target, expands them, then returns them after lymphodepleting treatment. | Apheresis + 3–6 weeks nearby | Per complete named programme | $80,000–$180,000 | View pediatric blood-care service |
| Autologous Stem Cell Transplant | An autologous stem cell transplant collects and cryopreserves the patient's own blood-forming stem cells, gives high-dose chemotherapy, then returns those cells to restore marrow production. | 3–5 weeks in or near the unit | Per complete named programme | $18,000–$48,000 | View pediatric blood-care service |
| Allogeneic Stem Cell Transplant | An allogeneic stem cell transplant replaces blood formation with stem cells from another person after conditioning and adds a donor immune effect against selected blood cancers or marrow disorders. | 6–10 weeks nearby | Per complete named programme | $30,000–$80,000 | View pediatric blood-care service |
| Haploidentical Stem Cell Transplant | A haploidentical transplant is an allogeneic transplant from a related donor who shares one HLA haplotype, commonly a parent, child or partially matched sibling. | 6–10 weeks nearby | Per complete named programme | $35,000–$85,000 | View pediatric blood-care service |
| Matched Unrelated Donor Transplant | A matched unrelated donor transplant is an allogeneic stem cell transplant using a volunteer donor selected through a registry by high-resolution HLA matching and medical suitability. | 6–12 weeks nearby | Per complete named programme | $40,000–$95,000 | View pediatric blood-care service |
| Pediatric Bone Marrow Transplantation | Pediatric bone marrow transplantation is a children’s-unit haematopoietic transplant: weight-based conditioning, a named paediatric isolation floor and a parent who can stay through the infection window, rather than an adult transplant admission that happens to accept a child. | 6–12 weeks with a parent nearby | Per complete named programme | $28,000–$75,000 | View pediatric blood-care service |
| Matched Sibling Donor Transplant | A matched sibling donor transplant is an allogeneic transplant in which a brother or sister is a fully HLA-matched donor after independent medical assessment, not simply because the children share a household. | 6–10 weeks with a parent nearby | Per complete named programme | $28,000–$70,000 | View pediatric blood-care service |
| Hematopoietic Stem Cell Transplantation | Hematopoietic stem cell transplantation in this catalog is the paediatric graft-source programme: marrow, peripheral-blood stem cells or cord blood chosen and dosed for a child’s weight, delivered by a named paediatric transplant physician on a unit that already treats children. | 4–10 weeks in a paediatric unit | Per complete named programme | $24,000–$70,000 | View pediatric blood-care service |
| Bone Marrow Biopsy | A bone marrow biopsy removes a small core of marrow, usually from the posterior pelvic bone, so architecture, cellularity, fibrosis and infiltrating disease can be examined by haematopathology. | Day-care | Per diagnostic or assessment episode | $300–$900 | View pediatric blood-care service |
| Bone Marrow Aspiration | Bone marrow aspiration withdraws liquid marrow, usually from the posterior iliac crest, for cell morphology, flow cytometry, cytogenetics, molecular testing or microbiology. | Day-care | Per diagnostic or assessment episode | $250–$800 | View pediatric blood-care service |
Indicative planning ranges, not guaranteed hospital quotations. The treating team confirms the clinical scope, billing basis, schedule, admission, monitoring and exclusions after review.
Clinical decisions
Selection begins with a confirmed diagnosis and a precise clinical question. Review includes age-specific disease classification and dosing and growth, fertility and late-effect considerations. A procedure name or scan finding alone is not enough to establish suitability.
The treating team considers family support, donor assessment and pediatric intensive-care access, current symptoms, medicines, previous treatment, comorbidities and the patient’s goals. Urgent or unstable illness may make travel inappropriate.
Alternatives and sequencing must be explicit. The specialist should explain why the proposed pediatric blood-care service is preferred, what result is expected to change care, and how recovery and follow-up will continue after the patient returns home.
Treatment pathway
This specialty-specific pathway is configured from approved editorial content. The exact sequence changes with the diagnosis, selected pediatric blood-care service and patient factors.
The pediatric hematologist reviews the diagnosis, prior treatment, current symptoms and original imaging or test material.
The team confirms age-specific disease classification and dosing, growth, fertility and late-effect considerations, family support, donor assessment and pediatric intensive-care access and identifies missing investigations or urgent risks.
Reasonable non-procedural, procedural and staged alternatives are compared with expected benefit and material risk.
The written plan identifies the exact pediatric blood-care service, technique, responsible clinician, campus and anticipated schedule.
Anaesthetic, medicine, infection, bleeding, organ-function and support requirements are checked as relevant.
The named team delivers care with procedure-specific safety checks and escalation arrangements.
The patient receives records, warning signs, medicine instructions, pending-result ownership and a follow-up plan.
Cost planning
Costs are shown by 2 compatible pricing bases rather than one misleading specialty-wide range. A personalized estimate follows medical-record review.
A pediatric hematology estimate is useful only when its billing basis and clinical scope are stated. Important scope includes weight-based treatment, diagnostic episode or transplant programme; pediatric ward, donor work, blood products, isolation and family accommodation. Unlike units must not be combined into one specialty average.
The written estimate should separate the named procedure or course from tests, professional fees, devices, medicines, pathology, ward care, intensive care and follow-up. Optional or complication-triggered charges should remain separate.
Catalog ranges are planning figures, not hospital quotations. The final amount can change after record review, examination, additional testing or a change in technique, device, duration or admission.
Technology
This list is derived from procedure relationships; it is not a hospital machine inventory. Technology availability must be confirmed for a named campus and treatment date.
What it is
The equipment, imaging, laboratory, anaesthetic and recovery resources required for the selected pediatric blood-care service.
Why it may be used
Availability must be confirmed for the named procedure, clinician, campus and treatment date rather than inferred from a hospital specialty label.
CAR-T Cell Therapy · Autologous Stem Cell Transplant · Allogeneic Stem Cell Transplant · Haploidentical Stem Cell Transplant · Bone Marrow Biopsy · Bone Marrow Aspiration · Matched Unrelated Donor Transplant · Pediatric Bone Marrow Transplantation · Matched Sibling Donor Transplant · Hematopoietic Stem Cell Transplantation
Cities
Cities appear only where current catalog relationships contain relevant hospitals, doctors and procedures. Counts update from the live data layer.
Hospitals
12 hospitals currently meet the India and Pediatric Hematology relationship filters. Cards show stored CMS information, not a ranking or universal capability claim.
JCI Accredited
NABH Accredited4 listed doctors for Pediatric Hematology
Languages listed: English, Hindi
JCI Accredited
NABH Accredited
NABL Accredited4 listed doctors for Pediatric Hematology
Languages listed: English, Tamil, Hindi
JCI Accredited
NABH Accredited
NABL Accredited3 listed doctors for Pediatric Hematology
Languages listed: English, Hindi
JCI Accredited
NABH Accredited
NABL Accredited2 listed doctors for Pediatric Hematology
Languages listed: English, Tamil, Hindi
JCI Accredited
NABH Accredited1 listed doctor for Pediatric Hematology
Languages listed: English, Hindi, Marathi
JCI Accredited
NABH Accredited1 listed doctor for Pediatric Hematology
Languages listed: English, Hindi
Specialists
21 doctor records meet the India and Pediatric Hematology relationship filters across 12 related hospitals. Profile facts come from the existing CMS; ordering is not a ranking.
Pediatric Hematology
32+ years Experience
Pediatric Bone Marrow Transplant · Pediatric Leukemia · Pediatric Thalassemia
English, Hindi
Pediatric Hematology
10+ years Experience
Pediatric Bone Marrow Transplant · Pediatric Leukemia · Pediatric Thalassemia
English, Hindi
Pediatric Hematology
10+ years Experience
Pediatric Bone Marrow Transplant · Haploidentical Bone Marrow Transplant · Bone Marrow Transplant (BMT)
English, Hindi
Pediatric Hematology
14+ years Experience
Pediatric Bone Marrow Transplant · Pediatric Leukemia · Pediatric Aplastic Anemia Treatment
English, Hindi
Pediatric Hematology
10+ years Experience
Pediatric Thalassemia · Pediatric Sickle Cell Disease · Pediatric Leukemia
English, Hindi
Pediatric Hematology
18+ years Experience
Pediatric Bone Marrow Transplant · Pediatric Sickle Cell Disease · Pediatric Thalassemia
English, Hindi
Pediatric Hematology
10+ years Experience
Pediatric Leukemia · Pediatric Thalassemia · Pediatric Sickle Cell Disease
English, Hindi
Pediatric Hematology
10+ years Experience
Pediatric Bone Marrow Transplant · Acute Leukemia · Pediatric Thalassemia
English, Hindi
International patients
Send the listed records before travel so a named pediatric hematologist can determine whether remote review is sufficient or further assessment is required. A preliminary opinion is not final clearance for treatment or flying.
Confirm the exact campus, clinician, procedure scope, estimate assumptions, expected stay, attendant needs and emergency arrangements before booking travel. Keep flights and lodging flexible until the clinical plan is accepted.
Before departure, obtain procedure and discharge records, pathology or test results, device details where relevant, medicine changes, warning signs and named contacts for pending results and follow-up at home.
Stay varies across the listed pediatric blood-care services; use the procedure row as planning guidance rather than a promise. The treating team decides observation, admission and fitness to fly after reviewing clinical risk and recovery.
International patients should allow time for assessment, pending results and an early review. A changed plan, complication or need for rehabilitation can extend the stay, so flexible travel arrangements are safer than a fixed departure immediately after treatment.
Depending on the condition, the treating team may request:
India has GAF-linked pediatric hematologists and hospitals across several cities. Compare a named clinician, campus and complete clinical scope rather than assuming all hospitals offer every pediatric blood-care service.
Compare like-for-like billing units, technique, devices, tests, admission, follow-up and exclusions. Travel cost and a headline procedure range should not outweigh clinical suitability, urgency or continuity of care.
Questions
A pediatric hematologist evaluates the relevant diagnosis, explains treatment options and coordinates procedure-specific assessment, delivery and follow-up.
Selection depends on age-specific disease classification and dosing, growth, fertility and late-effect considerations, family support, donor assessment and pediatric intensive-care access, prior treatment, current health, alternatives and the patient’s goals.
The table shows planning ranges by compatible billing basis. A personalized written estimate is required because one specialty average would combine unlike scopes.
Only items expressly named in the estimate are included. Confirm imaging, pathology, laboratory work, medicines, implants, disposables and monitoring.
The page lists catalog-connected pediatric hematologists. It is not a ranking, and the named clinician must accept and review the case.
Hospitals require a matching specialist relationship for this page. Confirm the exact procedure, clinician, campus, equipment and date directly.
Records commonly include Pediatric blood counts and smear reports, Marrow, flow-cytometry, cytogenetic and molecular reports, Growth chart, vaccination and infection history, plus current clinical notes and medicines.
Records can support a preliminary opinion, but final suitability may require examination, updated tests and review by the treating and anaesthesia teams.
Use each procedure’s typical course or stay as guidance. Recovery, results, complications and fitness to fly can change the plan.
Often, if the treating and home teams agree on records, medicines, warning signs, pending results and responsibility for follow-up.
No. A catalog relationship does not guarantee acceptance, equipment, scheduling or procedure availability at every campus.
No. Expected benefits and risks are individual, and no clinician or facilitator can guarantee an outcome.
Medical information notice: This page provides general educational and travel-planning information. GAF catalog ranges are indicative planning figures, not quotations, recommendations or promises of availability or outcome. Diagnosis, selection, technique, risks, recovery and fitness to travel must be decided by a qualified pediatric hematologist and relevant multidisciplinary clinicians after reviewing the patient and complete records.
Last medically reviewed: 2026-09-14 by Dr. Saffiyyah Chaudhary. Content curated by Dr. Shabnam Choudhary.
Dr. Shabnam Choudhary, BDS, is a dental professional who graduated from Al-Ameen Medical College, Bijapur, Karnataka. She contributes to the curation and development of medically informative healthcare content, helping ensure that information is structured clearly and presented in a patient-friendly manner.
Content Curator
BDS
Al-Ameen Medical College, Bijapur, Karnataka
Rajiv Gandhi University of Health Sciences (RGUHS), Bengaluru

Dr. Saffiyyah Chaudhary, BDS, is a dental professional who graduated from Al-Ameen Medical College, Bijapur, Karnataka. She provides medical review of healthcare content to help ensure that clinical information is accurate, understandable, and appropriately presented for patients and their families.
Medically Reviewed By
BDS
Al-Ameen Medical College, Bijapur, Karnataka
Rajiv Gandhi University of Health Sciences (RGUHS), Bengaluru

Patient stories
Google reviews
5.0 from 10 reviews on the GAF Healthcare Pvt Ltd Google listing.
★★★★★
Initially I was very hesitant what to do, where to go for the treatment of my father who was suffering with prostate cancer. Thanks to google, I came into touch with Gaf Healthcare. They have arranged everything, starting from treatment plan, video consultation, airport pickup, to surgery and following up. My father was operated in Sahyadri Pune, robotic prostatectomy was done. Now he is fine.
★★★★★
The hospitality was at its point. I appreciate the great service I got from the team. Being away from Home and get the feeling like you are at home is what Gaf is doing. Thank you once more, this have lifetime memories in my life.
★★★★★
Wonderful experience with Gaf Healthcare. I was quite hesitant before traveling. But the way entire journey has been planned, charted out and facilitated by Gaf was truly exceptional. Dr. Ritu in Max has treated me well. My eye surgery went well.
★★★★★
Very nice hospitality, I have taken my mother to Fortis Hospital with help of Gaf healthcare. Initially, I was anxious but these guys made me very comfortable and mama got treated well. Thank you so much guys.
Begin
10 pediatric blood-care services matching your filters